In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes.

Area of Science:

• Biotechnology
• Polymer Chemistry
• Molecular Biology

Background:

• RNA interference (RNAi) is a key therapeutic strategy for diseases.
• Effective delivery of small interfering RNA (siRNA) remains a challenge for clinical applications.
• Nanomaterials offer potential solutions for targeted and efficient siRNA delivery.

Purpose of the Study:

• To develop and evaluate cationic nanogel nanostructured polymers (NSPs) for in vitro and in vivo siRNA delivery.
• To assess the protective effect of NSPs on siRNA against enzymatic degradation.
• To demonstrate the efficacy of NSP-mediated RNAi in reducing target gene expression.

Main Methods:

• Synthesis of cationic nanogel NSPs using atom transfer radical polymerization (ATRP).
• Evaluation of siRNA protection against nucleases in vitro.
• Assessment of gene knockdown in mammalian cell culture (Gapdh) and in vivo mouse models (GFP).

Main Results:

• Nanogel NSPs demonstrated protection of siRNA against enzymatic degradation.
• NSP-mediated RNAi significantly reduced GAPDH enzyme activity in cell culture.
• In vivo studies showed significant inhibition of GFP expression in mice, dependent on siRNA sequence.
• siRNA methylation enhanced nuclease resistance without compromising gene knockdown.

Conclusions:

• Cationic nanogel NSPs are effective carriers for siRNA delivery, enhancing nuclease resistance and gene silencing.
• NSP/siRNA formulations show promise for therapeutic applications in disease models.
• Further development of NSP/siRNA compositions could lead to new therapeutic options.